The objectives of this project are to identify genes and gene networks that play a role in the development of obesity-induced type 2 diabetes. In the previous grant period, we carried out the first-ever study that surveyed pancreatic islet gene expression in an intercross. The intercross was derived from mouse strains resistant (C57BL/6 or B6) or susceptible (BTBR) to diabetes induced by the leptinob mutation. In addition to islets, we surveyed gene expression in five other tissues (liver, adipose, muscle, hypothalamus, and kidney). All mice were genotyped for 5,000 single nucleotide polymorphisms between B6 and BTBR. We surveyed >100 clinical traits in the F2 sample, as well as hundreds of micro-RNAs (miRNAs) in liver. Our studies have yielded an unprecedented dataset, allowing us to develop causal regulatory networks that predict the interaction among genes, intermediate phenotypes such as miRNAs and mRNAs, and downstream clinical traits. Specifically these studies have allowed us to: 1) identify expression quantitative trait loci (eQTLs); 2) identify """"""""hotspots"""""""", or large sets of transcripts that appear to be co-regulated by a single locus; 3) use genetics as an anchor to develop directional eQTL network models;and 4) integrate eQTL network models with key physiological phenotypes related to obesity and diabetes. Taken together, the genetic architecture (eQTL and hotspots) and reconstructed networks have identified genomic regions and genes that may contain regulatory elements that underlie the physiology of obesity-dependent type 2 diabetes. We have used our methods for network construction to identify genes that are closely associated with clinical phenotypes.
The specific aims of this proposal are to: 1) Identify and test regulatory genomic loci that govern pancreatic islet cell cycle genes essential for ?-cell replication. Refine and experimentally test models that predict the causal relationship between the regulatory loci and islet cell cycle genes responsible for the proliferative capacity of ?-cells;2) Identify and test the regulatory genomic loci governing hepatic steatosis. Construct and refine network models that relate co-regulated hepatic genes with accumulation of liver triglycerides;3) Utilize the heritability of miRNA abundance to predict mRNA targets and relate miRNAs, mRNAs and clinical phenotypes with testable models. Successful completion of Specific Aims 1 - 3 is critically dependent on the development of novel statistical and computational methods. These will include methods to: a) resolve genetic intervals to which multiple physiological and expression traits map;b) extend our network reconstruction approach to infer dependence among traits and incorporate prior information;and c) identify differentially correlated gene sets.
This project is aimed at understanding the genetic factors responsible for obesity- induced type 2 diabetes. We use genetic and genomic approaches to identify genes that are causally related to the key metabolic and pathological processes underlying this disease. Our research will help to understand how some, but not all obese people become diabetic and perhaps develop biomarkers to identify individuals at greatest risk for developing diabetes.
|Gu, Tongjun; Gatti, Daniel M; Srivastava, Anuj et al. (2016) Genetic Architectures of Quantitative Variation in RNA Editing Pathways. Genetics 202:787-98|
|Tian, Jianan; Keller, Mark P; Broman, Aimee Teo et al. (2016) The Dissection of Expression Quantitative Trait Locus Hotspots. Genetics 202:1563-74|
|Tian, Jianan; Keller, Mark P; Oler, Angie T et al. (2015) Identification of the Bile Acid Transporter Slco1a6 as a Candidate Gene That Broadly Affects Gene Expression in Mouse Pancreatic Islets. Genetics 201:1253-62|
|Shortreed, Michael R; Wenger, Craig D; Frey, Brian L et al. (2015) Global Identification of Protein Post-translational Modifications in a Single-Pass Database Search. J Proteome Res 14:4714-20|
|Shang, Jin; Li, Jing; Keller, Mark P et al. (2015) Induction of miR-132 and miR-212 Expression by Glucagon-Like Peptide 1 (GLP-1) in Rodent and Human Pancreatic Î²-Cells. Mol Endocrinol 29:1243-53|
|Broman, Karl W; Keller, Mark P; Broman, Aimee Teo et al. (2015) Identification and Correction of Sample Mix-Ups in Expression Genetic Data: A Case Study. G3 (Bethesda) 5:2177-86|
|Bhatnagar, Sushant; Soni, Mufaddal S; Wrighton, Lindsay S et al. (2014) Phosphorylation and degradation of tomosyn-2 de-represses insulin secretion. J Biol Chem 289:25276-86|
|Soni, Mufaddal S; Rabaglia, Mary E; Bhatnagar, Sushant et al. (2014) Downregulation of carnitine acyl-carnitine translocase by miRNAs 132 and 212 amplifies glucose-stimulated insulin secretion. Diabetes 63:3805-14|
|Munger, Steven C; Raghupathy, Narayanan; Choi, Kwangbom et al. (2014) RNA-Seq alignment to individualized genomes improves transcript abundance estimates in multiparent populations. Genetics 198:59-73|
|Ulbrich, Arne; Merrill, Anna E; Hebert, Alexander S et al. (2014) Neutron-encoded protein quantification by peptide carbamylation. J Am Soc Mass Spectrom 25:6-9|
Showing the most recent 10 out of 46 publications